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Abstract
The SARS coronavirus (SARS-CoV) open reading frame 7a (ORF 7a) encodes a 122 amino acid accessory protein. It
has no significant sequence homology with any other known proteins. The 7a protein is present in the virus parti-
cle and has been shown to interact with several host proteins; thereby implicating it as being involved in several
pathogenic processes including apoptosis, inhibition of cellular protein synthesis, and activation of p38 mitogen
activated protein kinase. In this study we present data demonstrating that the SARS-CoV 7a protein interacts with
human Ap4A-hydrolase (asymmetrical diadenosine tetraphosphate hydrolase, EC 3.6.1.17). Ap4A-hydrolase is respon-
sible for metabolizing the “allarmone” nucleotide Ap4A and therefore likely involved in regulation of cell prolifera-
tion, DNA replication, RNA processing, apoptosis and DNA repair. The interaction between 7a and Ap4A-hydrolase
was identified using yeast two-hybrid screening. The interaction was confirmed by co-immunoprecipitation from
cultured human cells transiently expressing V5-His tagged 7a and HA tagged Ap4A-hydrolase. Human tissue culture
cells transiently expressing 7a and Ap4A-hydrolase tagged with EGFP and Ds-Red2 respectively show these proteins
co-localize in the cytoplasm.
Background
Severe acute respiratory syndrome coronavirus (SARS-
CoV) has been shown to be the etiological agent for the
global SARS outbreak in the winter 2002/2003 that
affected about 30 countries [1].
SARS-CoV is an enveloped, positive-sense RNA virus
with ~30 kb genome. It contains 14 potential ORFs.
S o m eo ft h e s eO R F se n c o d ep r o t e i n st h a ta r eh o m o l o -
gues to the structural proteins founded in other corona-
viruses, namely the replicase (ORF 1a and 1b),
membrane, nucleocapsid, envelope and spike proteins
[2,3]. Other ORFs encode group-specific or accessory
proteins which are unique to SARS-CoV.
Accessory proteins are not necessary for viral replica-
tion in cell culture systems and in mice, but may be
important for virus-host interactions and thus may con-
tribute to viral strength and/or pathogenesis in vivo
[4-6].
Protein 7a (also known as ORF 8, U122 and X4 pro-
tein [2,3,7]), 122 amino acids in length, shows no signifi-
cant similarity to any other viral or non-viral proteins.
The ORF 7a gene is conserved in all SARS-CoV strains
[8], and sequence analysis predicts that ORF 7a encodes
a type I transmembrane protein. The crystal structure of
the luminal domain of the 7a protein has been resolved,
revealing a structure unexpectedly similar in fold and
topology to members of the immunoglobulin superfam-
ily [9]. It has been demonstrated that 7a is incorporated
into SARS-CoV particles by interacting with viral struc-
tural proteins E and M [10,11]. In addition, 7a interacts
with the viral proteins 3a and S [10,12], and these pro-
teins may form a complex during viral infection.
Recombinant mutant SARS-CoV lacking the 7a gene
is completely viable in cultural cells and mice [4]; there-
fore, 7a protein is dispensable for virus growth and
replication but may play role in virus-host interactions.
The 7a protein seems to have diverse biological func-
tions in cultured cells. Over-expression of ORF 7a
induces apoptosis via the caspase-dependent pathway
[13] and inhibits cellular protein synthesis by activation
of p38 MAPK [14]. The induction of apoptosis by the
7a protein is dependent on its interaction with the Bcl-
XL protein and other pro-survival proteins (Bcl-2, Bcl-w,
Mcl-1 and A1) [15]. In addition, 7a can block cell cycle
progression at the G0/G1 phase via the cyclin D3/pRb
pathway [16]. Also, interaction between 7a and hSGT
(human small glutamine-rich tetricopeptide repeat
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biological significance of this interaction needs to be
further elucidated [17]. Taken together, these observa-
tions suggest that the 7a protein interacts with several
host cell proteins and may play a role in the SARS-CoV
pathogenesis.
We performed a yeast-two-hybrid screening using a
commercially prepared human lung cDNA library as the
source of the “prey” cDNAs and using a full-length ORF
7a as the “bait”. Among the potential novel 7a interact-
ing partners, Ap4A-hydrolase was identified. Its interac-
tion with 7a was confirmed by co-immunoprecipitation
and co-localization experiments in transiently trans-
fected cultured human cells.
Ap4A-hydrolase belongs to the Nudix (nucleoside
diphosphate linked to x) hydrolases, which are a super-
family of enzymes required for maintenance of physiolo-
gical homeostasis by metabolizing signaling molecules
and potentially toxic substances. Ap4A-hydrolase is
found in all higher eukaryotes and contributes to regula-
tion of the intracellular level of “allarmone” nucleotide
Ap4A [18,19]. It is an asymmetrically-cleaving enzyme,
catalyzing the reaction (Ap4®ATP+AMP). The intracel-
lular concentration of Ap4A has been shown to increase
in cells after heat, oxidative, nutritional or DNA damage
stresses [20]. A recent study demonstrated that Ap4A-
hydrolase belongs to the transcriptional regulation net-
work in immunologically activated mast cells and that it
is involved in regulation of the MITF gene in cardiac
cells [21].
Results
Identification of human cellular proteins interacting with
SARS-CoV protein 7a
In order to identify cellular proteins that interact with
the 7a protein, we performed a yeast two-hybrid screen-
ing of the Hybrid Hunter™ Premade cDNA library
(human adult lung) constructed in pYESTrp2 (Invitro-
gen). Approximately 1 × 10
6 transformants were
s c r e e n e d .F r o mt h e s e ,3 5c l o n e sw e r ea b l et og r o wi n
the selective media (-Trp, -Leu, -His) and gave a strong
signal when analyzed for b-galactosidase activity. Plas-
mid DNA from the positive yeast clones was purified
and used for transformation of the E. coli strain DH5a.
Next, the DNA of the plasmids was sequenced and ana-
lyzed using BLAST. One of the clones contained a com-
plete ORF that showed sequence identity to the human
Ap4A-hydrolase gene [GenBank: U30313].
Co-immunoprecipitation
To verify interactions established by the yeast two-
hybrid screening, we used a co-immunoprecipitation
assay. HEK 293 cells were either transfected with pXJ3’-
ORF7a-HA, or co-transfected with both pXJ3’-ORF7a-
HA and pcDNA3.1/V5-His -Ap4A. The transfected cells
were lysed 24-48 h after transfection. Protein extracts
were immunoprecipitated using monoclonal Anti-V5
antibody (Fig. 1, lanes 1 and 2). As a negative control,
the same protein extracts were immunoprecipitated
using an unrelated antibody - mouse monoclonal anti-b-
actin (Fig. 1, lane 4). Antibody-antigen complexes were
immobilized on protein A and G-sepharose bead mix-
ture. The immobilized proteins were eluted by boiling
the beads in SDS-PAGE loading buffer. The samples
were subsequently analyzed by Western blot, using an
anti-HA monoclonal antibody, to detect HA tagged co-
immunoprecipitated proteins. As shown in Fig. 1, the
HA-tagged 7a protein co-immunoprecipitated with V5-
tagged Ap4A-hydrolase. As described earlier [12], the 7a
protein was detected in the transfected cells in two
forms: unprocessed and processed. The 7a protein was
not detected when unrelated antibody was used for co-
immunoprecipitation. Our results indicate that 7a speci-
fically interacts with Ap4A-hydrolase in human cells.
Subcellular co-localization of 7a and Ap4A-hydrolase
There is no consensus opinion in subcellular localization
of 7a protein [for review see [11]]. 7a protein was found
co-locolaze with trans-Golgi marker, Golgin97 [9], in
the Golgi compartment [14]. Other reports demon-
strated co-localization with endoplasmic reticulum mar-
ker GRP94 or the intermediate compartment marker
Sec 31 [7,17]. Since the co-immunoprecipitation experi-
ment showed interaction between HA- tagged 7a and
V5-tagged Ap4A-hydrolase, we hypothesized that these
proteins may co-localize in human cells. To visualize
these proteins, we tagged them with fluorescent pro-
teins: 7a with EGFP and Ap4A-hydrolase with DsRed2.
HEK 293 cells were co-transfected with pEGFP-C2-
ORF7a and pDsRed2-Ap4A, and sub-cellular distribution
of proteins was examined by confocal microscopy.
Our data demonstrated that both proteins had similar
cytoplasmic localization (Fig. 2, left and middle panels).
Co-localization analysis showed an overlap in the sub-
cellular distribution of both proteins, as can be seen by
the appearance of the yellow color in the overlaid image
(Fig. 2, right panel).
Discussion
The molecular mechanisms of SARS-CoV pathogenesis
are not fully understood and the contribution of the
group-specific proteins, also known as accessory pro-
teins, to this process has not been completely deter-
mined. The study of interactions between viral and
cellular proteins may help to elucidate molecular
mechanisms of SARS-CoV pathogenicity. In our study,
we have shown an interaction between the 7a protein
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of biological processes [18-21].
Interaction between 7a protein and Ap4A-hydrolase
was initially found in the yeast two-hybrid system and
then confirmed in human cells. Human lung cDNA
library was used for initial screening because although
SARS-CoV may affect various organs and tissues, its pri-
mary site of infection is the respiratory tract [22,23].
The interaction that has been found in yeast was con-
firmed by co-immunoprecipitation analysis carried out
with the recombinant proteins extracted from the trans-
fected HEK 293 cells (Fig. 1) and confocal microscopy
of these cells (Fig. 2).
The substrate of Ap4A-hydrolase, Ap4A, can be found
in all organisms including Archae and humans, and it is
a side product of protein synthesis catalyzed by amino-
acyl-tRNA synthetases [21]. Although the biological sig-
nificance of Ap4A is not fully understood, it has been
proposed to be an intracellular and extracellular signal-
ing molecule affecting cell proliferation and DNA repli-
cation [18,24,25], RNA processing [26,27], heat shock
and oxidative stress [19,28], apoptosis and DNA repair
[29]. As an extracellular component, Ap4A may play an
important role as a neurotransmitter in the cardiovascu-
lar system [30,31]. In bacteria, Ap4A levels may also
play a role in invasion [32,33].
Multiple pathways may be involved in the regulation
of apoptosis and cell cycle arrest during SARS-CoV
infection. It is well established that over-expression of
7a protein in cultured cells induces apoptosis via
increasing level of caspase-3 protease activity [13]. Inter-
estingly, Ap4A is also involved in caspase activation [34].
Elevation of Ap4A level could be achieved by direct up-
regulation of the amino-acyl-tRNA synthetases, or
down-regulation of the Ap4A-hydrolases, or both, in
response to the appropriate signal. Our data indicate
that 7a interacts with Ap4A-hydrolase and thus may
down-regulate the Ap4A-hydrolase enzymatic activity.
Theoretically, this would result in an increase of Ap4A
level and contribute to the induction of apoptosis.
Further study is required to confirm this hypothesis.
Protein 7a has been reported to interact with Bcl-2
protein and several other prosurvival members of Bcl-2
family [16]. Anti-apoptotic Bcl-2 protein inhibits cas-
pase-dependent apoptosis induced by SARS-CoV infec-
tion but does not affect viral replication kinetics [35]. It
Figure 1 Co-immunoprecipitation of Ap4 A-hydrolase and the SARS-CoV 7a protein. HEK 293 cells were transiently transfected with
pcDNA3.1/V5-His-Ap4A and/or pXJ-7a-HA. Proteins from cell lysates were immunoprecipitated with monoclonal anti-V5 antibodies (lanes 1 and
2) or unrelated monoclonal anti-b-actin antibody (lane 4). After immunoprecipitation, samples were subjected to 12% SDS-PAGE, transferred to
nitrocellulose membrane and probed with monoclonal anti-HA antibodies. Lane 3 represents Western blotting of cell lysates without
immunoprecipitation as a control.
Figure 2 Co-localization of EGFP-tagged 7a and DsRed2-tagged
Ap4 A-hydrolase in transiently transfected HEK 293 cells. The
cells were grown on 35 mm glass bottom culture dishes and were
subjected to confocal microscopy using a Zeiss LSM410 microscope,
as described in Material and Methods. Both signals were detected
simultaneously; separate images were taken and superimposed. Left
panel shows the cellular distribution of transiently expressed EGFP-
tagged 7a. Middle panel shows red fluorescence of DsRed2-tagged
Ap4A-hydrolase in the same cells. Right panel represents a
superimposition of both images.
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accompanied by a significant reduction in the level of
anti-apoptotic Bcl-2 protein in mammalian cells [36].
Since Bcl-2 is a substrate of caspase-3 in myeloid leuke-
mic cells, Vartanian and co-workers suggested that
Ap4A is involved in the cascade of events leading to cas-
pase activation [34,36].
Cell cycle disregulation is a common response of host
cells to many viral infections. Some SARS-CoV proteins,
including nucleocapsid N [37], 3b [38] and 7a [15] block
cell cycle progression at the G0/G1 phase. As for 7a, it
has been demonstrated that its expression inhibits phos-
phorylation of one of the key regulators of cell cycle
progression - Rb protein [15]. The hyperphosphorylation
of Rb allows activation of E2F family of transcription
factors, permitting the transcription of the S phase
genes [39]. The inhibition of Rb phosphorylation by 7a
suggests that the expression of G1 cyclin/cdk complexes
is suppressed. On the other hand, flow cytometric analy-
sis indicated an involvement of Ap4A at an early stage
of G1/S arrest by dephosphorylation of pRb via reduc-
tion of CDK 2 activity [36].
Taken together, these data suggest that 7a and Ap4A-
hydrolase may be involved in a common cascade of
mechanisms leading to cell cycle arrest and apoptosis.
Further insight into the functions of both 7a protein
and Ap4A-hydrolase will still have to be gained before
the physiological importance of their interactions can be
elucidated. In addition, more experiments are required
to determine the significance of the obtained data. For
instance, co-immunoprecipitation and co-localization
assays need to be repeated using SARS-CoV infected
cells and protein-specific anti-sera. Also, it will be useful
to infect cells with SARS-CoV carrying a deletion of the
7a gene [4] in order to study apoptosis and cell cycle
regulation in the infected cells.
Conclusions
The study of interactions between viral and cellular pro-
teins may help to elucidate molecular mechanisms of
SARS-CoV pathogenicity. In the present paper, we have
shown an interaction between the SARS-CoV 7a protein
and Ap4A-hydrolase, an enzyme involved in a number
of biological processes. These two proteins may partici-
pate in common pathways leading to cell cycle arrest
and apoptosis. The biological significance of the interac-




The plasmid pXJ3’-ORF7a-HA containing full-length
SARS-CoV ORF 7a with C-terminal HA-tag was a gen-
erous gift from Dr. Yee-Joo Tan (Institute of Molecular
and Cell Biology, Singapore) and has been described
elsewhere in detail [12].
In our study, the ORF 7a gene was amplified from
RNA of SARS-CoV-infected Vero E6 cells (strain Tor 2)
using a one step RT PCR kit (Qiagen, Mississauga,
Canada) (primers 5’-GGGGTACCATGAAAAT-
TATTCTCTTCCT-3’ and 5’-GGAATTCT-
CATTCTGTCTTTCTCTTAA-3’) and cloned into the
Kpn Ia n dEcoR I sites (underlined) of the pH5L vector
[40] to create pH5L-ORF7a. Next, ORF 7a was amplified
from the plasmid pH5L-ORF7a using primers 5’-
CGGAATTCATGTTTCATCTTGTTGACTT-3’ and 5’-
CGCTCGAGTTATGGATAATCTAACTCCA-3’.T h e
PCR-product was digested with EcoRIa n dXho I
(recognition sites are underlined) and subcloned into
pHybLex/Zeo (Invitrogen, Burlington, Canada) in frame
with LexA to create the “bait” pHybLex/Zeo-ORF7a
plasmid for yeast two-hybrid library screening. Then,
pH5L-ORF7a was digested with EcoRIa n dXho Ia n d
the DNA fragment containing ORF 7a was cloned into
EcoRIa n dXho I sites of pEGFP-C2 (Clontech, Moun-
tain View, USA) resulting in pEGFP-C2-ORF7a where
ORF 7a was fused to the C-terminus of EGFP.
The plasmid containing the human full-length Ap4A-
hydrolase gene was recovered from the yeast clone as
described below. The gene was amplified by PCR using
the specific primers 5’-GCGGATCCAGATGGCCTT-
GAGAGCATG-3’ and 5’-CGCTCGAGGGGCCTC-
TATGGAGCAAAGA-3’ and subcloned into BamHI
and Xho I site (underlined) of pcDNA3.1/V5-HisA vec-
tor (Invitrogen) to construct pcDNA3.1/Ap4AV 5 - H i s
where V5-His tag was attached to the C-terminus of
Ap4A-hydrolase. Also, the gene encoding Ap4A-hydro-
lase was subcloned into the Hind III and EcoR I sites of
pDsRed2 (Clontech) (primers 5’-TTAAGCT-
TATGGCCTTGAGAGCATGTG-3’ and 5’-
GTGAATTCGTGCCTCTATGGAGCAAAG-3’)r e s u l t -
ing in pDsRed2-Ap4A where DsRed2 was fused to the
C-terminus of Ap4A-hydrolase. The sequences of all
constructs were confirmed by sequencing.
Yeast two-hybrid screening
The Hybrid Hunter™ yeast two-hybrid kit was purchased
from Invitrogen, and all experiments were carried out as
recommended by the manufacturer. Briefly, the full-
length cDNA of ORF 7a was cloned into pHybLex/Zeo
to create a “bait” gene construct pHybLex/Zeo-ORF7a
as described above. Hybrid Hunter™ Premade cDNA
library (human adult lung) constructed in pYESTrp2
(Invitrogen) was used as a source of “prey” genes.
The plasmid pHybLex/Zeo-ORF7a was used to trans-
form the yeast strain EGY48/pSH18-34, using the
lithium acetate method to create a “bait” yeast strain.
Next, the “bait” yeast strain was transformed with the
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growth in the absence of uracil, leucine, histidine and
tryptophane and further tested for b-galactosidase activ-
ity using a filter assay, as suggested by Invitrogen.
Plasmid DNA was isolated from the positive yeast
clones. The gene inserts were PCR amplified and then
sequenced. Plasmid DNA from positively interacting
clones was also re-transformed into the E. coli DH5a
strain.
Cell culture and transfection
HEK 293 cells (ATCC CRL-1573) were maintained in
minimal Eagle medium (Invitrogen) supplemented with
10% fetal bovine serum, 1% nonessential amino acids,
1% HEPES and 0.05 mg/ml gentamicin (Invitrogen).
Cells were cultured at 37° in an incubator supplied with
5% CO2.
Cells were transiently transfected with expression vec-
tors using the Profection Mammalian Transfection Sys-
tem-Calcium Phosphate (Promega, Madison, USA), in
accordance with the manufacturer’si n s t r u c t i o n .F r o m
24 to 48 h after transfection, the expression of proteins
was screened by Western-blot and confocal microscopic
analysis.
Antibodies
The following antibodies were used in the present study:
monoclonal mouse Anti-V5 antibody (Invitrogen), dilu-
tion 1:1000; monoclonal mouse anti-HA Tag antibody
(Upstate, Temecula, USA), dilution 1:5000; monoclonal
mouse anti-b-actin (Sigma-Aldrich, Oakville, Canada),
dilution 1:2000; and goat anti-mouse horseradish peroxi-
dase conjugated IgG (BioRad, Mississauga, Canada),
dilution 1:2000.
SDS-PAGE and Western blotting
At 48 h after transfection, HEK293 cells were lysed in
RIPA buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl,
1% NP-40, 1% deoxicholate Na, 0.1% SDS and 1 mM
PMSF). After incubation on ice for 30 min, the samples
were briefly sonicated on ice and centrifuged. Superna-
tants were subjected to 12% SDS-PAGE and were trans-
ferred to a nitrocellulose membrane (Ready Gel™
Blotting Sandwiches from BioRad). After incubation
with blocking buffer (5% non-fat dry milk in TBST (20
mM Tris-HCl, pH 7.0, 150 mM NaCl, 0.05% Tween-
20)), membranes were incubated with specific primary
antibodies, washed three times in TBS-T, and then incu-
bated with horseradish-peroxidase-conjugated secondary
antibodies. The resulting signals were visualized by the
ECL- Plus Western Blotting Detection System (GE
Healthcare, Baie d’Urfe, Canada).
Co- Immunoprecipitation
Cells in 6-well culture plates (5 × 10
5 cells per well)
were transiently co-transfected with 3 μgp X J 3 ’-ORF7a-
HA and 3 μg pcDNA3.1/V5-His-Ap4A using the Profec-
tion Mammalian Transfection System-Calcium Phos-
phate (Promega, Madison, USA). At 48 h after
transfection, cells were harvested and washed twice with
ice-cold PBS. Cell lysates were prepared in IP-lysis buf-
fer (10 mM HEPES, pH 7.2, 150 mM NaCl, 1 mM
PMSF, 1% Nonident-40). The supernatants were incu-
bated with monoclonal Anti-V5 antibody, or anti-HA
Tag antibody or anti-b-actin antibody overnight at 4°C.
After the incubation, protein A/G Sepharose Fast Flow
beads (GE HealthCare) were added and the samples
were incubated for additional 1 h at 4°C. The beads
were washed five times with IP-lysis buffer, boiled in
SDS sample buffer, and subjected to Western blot
analysis.
Confocal microscopy
HEK 293 cells, co-transfected with pDsRed2-Ap4Aa n d
pEGFP-C2-ORF7a, were grown on 35 mm glass bottom
culture dishes (Mattek, Ashland, USA). At 24 h post
transfection, cells were analyzed using a confocal micro-
scope Zeiss LSM410 equipped with external Argon Ion
Laser. EGFP was excited by Argon Ion Laser Beam (488
nm) while DsRed2 was excited by Helium/Neon Laser
beam (594 nm). Both signals were detected simulta-
neously, and separate images were taken and
superimposed.
List of abbreviations
SARS-CoV: severe acute respiratory syndrome corona-
virus; Ap4A hydrolase: asymmetrical diadenosine tetra-
phosphate hydrolase (EC 3.6.1.17); ORF: open reading
frame; EGFP: enhanced green fluorescent protein;
DsRed: Discosoma sp. red fluorescent protein; HEK:
human embryo kidney; PBS: phosphate buffered saline;
MAPK: mitogen-activated protein kinase; Rb: retinoblas-
toma; CDK2: cyclin dependent kinase 2.
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